Oncogenomic

Oncogenomic combines oncology and genomics to explore the genetic basis of cancer. It identifies genetic mutations, alterations, and expression changes that drive cancer development and progression. Using technologies like next-generation sequencing (NGS), oncogenomic analyzes cancer genomes to pinpoint mutations and other genomic alterations. It distinguishes between driver mutations, which contribute to cancer, and passenger mutations, which do not. The field also examines gene expression and epigenetic changes, offering insights into cancer progression. Oncogenomic supports personalized treatments, identifies new biomarkers, and aids in developing targeted therapies and immunotherapies, promising advancements in cancer diagnosis and treatment.